Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs

(2010) Elaine H. Morrato et al.   ARCHIVES OF GENERAL PSYCHIATRY

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

(2009) S. M. Stahl et al.   ACTA PSYCHIATRICA SCANDINAVICA

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comorbid Somatic Illnesses in Patients With Severe Mental Disorders

(2009) W. Wolfgang Fleishhacker et al.   JOURNAL OF CLINICAL PSYCHIATRY

Second-Generation Antipsychotic–Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need

(2009) Dan Cohen et al.   JOURNAL OF CLINICAL PSYCHIATRY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

The incidence of diabetes in atypical antipsychotic users differs according to agent-results from a multisite epidemiologic study

(2009) Marianne Ulcickas Yood et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The metabolic syndrome and schizophrenia

(2008) J. M. Meyer et al.   ACTA PSYCHIATRICA SCANDINAVICA

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis

(2008) M. Smith et al.   BRITISH JOURNAL OF PSYCHIATRY

Olanzapine Versus Aripiprazole for the Treatment of Agitation in Acutely Ill Patients With Schizophrenia

(2008) Bruce J. Kinon et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

(2008) René S Kahn et al.   LANCET

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH

Course of illness in a sample of 265 patients with first-episode psychosis—Five-year follow-up of the Danish OPUS trial

(2008) Mette Bertelsen et al.   SCHIZOPHRENIA RESEARCH